Evidence map›Paper›PMID 30710047›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

l-Arginine Synthesis from l-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo.

Shannon M Lange, Melanie C McKell, Stephanie M Schmidt, Junfang Zhao, Rebecca R Crowther, Lisa C Green, Rebecca L Bricker, Eusondia Arnett, S Eleonore Köhler, Larry S Schlesinger and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Arginine utilization inInfection and immunity · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Cutting Edge: l-Arginine Transfer from Antigen-Presenting Cells Sustains CD4Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Shannon M LangeDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.ORCID 0000-0003-3907-6072
Melanie C McKellDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Stephanie M SchmidtDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Junfang ZhaoMass Spectrometry Core, Division of Pathology and Laboratory Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.ORCID 0000-0003-1777-5665
Rebecca R CrowtherDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.ORCID 0000-0003-3190-9498
Lisa C GreenDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Rebecca L BrickerDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229.
Eusondia ArnettTexas Biomedical Research Institute, San Antonio, TX 78245; and.
S Eleonore KöhlerDepartment of Anatomy and Embryology, Maastricht University, 6229 HA Maastricht, the Netherlands.
Larry S SchlesingerTexas Biomedical Research Institute, San Antonio, TX 78245; and.
Kenneth D R SetchellMass Spectrometry Core, Division of Pathology and Laboratory Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.ORCID 0000-0001-9147-0136
Joseph E QuallsDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229; joseph.qualls@cchmc.org.ORCID 0000-0002-0113-2166
Cincinnati Children's Hospital Medical Center · USTexas Biomedical Research Institute · USMaastricht University · NL

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
L-citrulline and anti-tuberculosis host defenseR01AI116668 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI QUALLS, JOSEPH E · 2016 to 2020
$1.9M
NCATS NIH HHS UL1 TR001425NIAID NIH HHS R01 AI116668NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

Immunonutrition as a therapeutic approach is rapidly gaining interest in the fight against infection. Targeting l-arginine metabolism is intriguing, considering this amino acid is the substrate for antimicrobial NO production by macrophages. The importance of l-arginine during infection is supported by the finding that inhibiting its synthesis from its precursor l-citrulline blunts host defense. During the first few weeks following pulmonary mycobacterial infection, we found a drastic increase in l-citrulline in the lung, even though serum concentrations were unaltered. This correlated with increased gene expression of the l-citrulline-generating (i.e., iNOS) and l-citrulline-using (i.e., Ass1) enzymes in key myeloid populations. Eliminating l-arginine synthesis from l-citrulline in myeloid cells via conditional deletion of either

Indexed as

AnimalsArginineCitrullineMiceMice, Inbred C57BLMice, Mutant StrainsMycobacterium InfectionsMyeloid CellsRespiratory Tract InfectionsArginineCitrulline

Identifiers

PMID30710047
PMCPMC6401247
OpenAlexW2914213505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.